| Literature DB >> 22231702 |
Andrew L Rankin1, Heath Guay, Deborah Herber, Sarah A Bertino, Tatyana A Duzanski, Yijun Carrier, Sean Keegan, Mayra Senices, Nancy Stedman, Mark Ryan, Laird Bloom, Quintus Medley, Mary Collins, Cheryl Nickerson-Nutter, Joe Craft, Deborah Young, Kyri Dunussi-Joannopoulos.
Abstract
MRL/MpJ-Fas(lpr/lpr)/J (MRL(lpr)) mice develop lupus-like disease manifestations in an IL-21-dependent manner. IL-21 is a pleiotropic cytokine that can influence the activation, differentiation, and expansion of B and T cell effector subsets. Notably, autoreactive CD4(+) T and B cells spontaneously accumulate in MRL(lpr) mice and mediate disease pathogenesis. We sought to identify the particular lymphocyte effector subsets regulated by IL-21 in the context of systemic autoimmunity and, thus, generated MRL(lpr) mice deficient in IL-21R (MRL(lpr).IL-21R(-/-)). Lymphadenopathy and splenomegaly, which are characteristic traits of the MRL(lpr) model were significantly reduced in the absence of IL-21R, suggesting that immune activation was likewise decreased. Indeed, spontaneous germinal center formation and plasma cell accumulation were absent in IL-21R-deficient MRL(lpr) mice. Correspondingly, we observed a significant reduction in autoantibody titers. Activated CD4(+) CD44(+) CD62L(lo) T cells also failed to accumulate, and CD4(+) Th cell differentiation was impaired, as evidenced by a significant reduction in CD4(+) T cells that produced the pronephritogenic cytokine IFN-γ. T extrafollicular helper cells are a recently described subset of activated CD4(+) T cells that function as the primary inducers of autoantibody production in MRL(lpr) mice. Importantly, we demonstrated that T extrafollicular helper cells are dependent on IL-21R for their generation. Together, our data highlighted the novel observation that IL-21 is a critical regulator of multiple pathogenic B and T cell effector subsets in MRL(lpr) mice.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22231702 PMCID: PMC3618484 DOI: 10.4049/jimmunol.1003871
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422